Pulmonx Price to Sales Ratio 2019-2023 | LUNG

Historical PS ratio values for Pulmonx (LUNG) over the last 10 years. The current P/S ratio for Pulmonx as of May 03, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pulmonx P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-05-03 9.82 5.42
2023-12-31 12.75 $1.81 7.03
2023-09-30 10.33 $1.72 6.00
2023-06-30 13.11 $1.62 8.09
2023-03-31 11.18 $1.54 7.25
2022-12-31 8.43 $1.45 5.82
2022-09-30 16.66 $1.41 11.79
2022-06-30 14.72 $1.41 10.42
2022-03-31 24.81 $1.37 18.05
2021-12-31 32.07 $1.34 23.88
2021-09-30 35.98 $1.93 18.65
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.361B $0.069B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.527B 19.51
Inspire Medical Systems (INSP) United States $7.610B 0.00
IRhythm Technologies (IRTC) United States $3.451B 0.00
Axonics (AXNX) United States $3.424B 0.00
10x Genomics (TXG) United States $3.133B 0.00
Azenta (AZTA) United States $2.932B 238.96
Olink Holding AB (publ) (OLK) Sweden $2.862B 0.00
Enovis (ENOV) United States $2.859B 21.19
Hims & Hers Health (HIMS) United States $2.622B 0.00
Privia Health (PRVA) United States $2.184B 96.89
Schrodinger (SDGR) United States $1.677B 0.00
Omnicell (OMCL) United States $1.345B 46.49
Phreesia (PHR) United States $1.255B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.734B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.701B 0.00
Fulgent Genetics (FLGT) United States $0.635B 0.00
Talkspace (TALK) United States $0.531B 0.00
Health Catalyst (HCAT) United States $0.386B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.331B 0.00
Clover Health Investments (CLOV) United States $0.319B 0.00
Butterfly Network (BFLY) United States $0.192B 0.00
P3 Health Partners (PIII) United States $0.189B 0.00
Outset Medical (OM) United States $0.155B 0.00
American Well (AMWL) United States $0.151B 0.00
Augmedix (AUGX) United States $0.130B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
TruBridge (TBRG) United States $0.125B 5.32
111 (YI) China $0.094B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
NantHealth (NHIQ) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.056B 0.00
Movano (MOVE) United States $0.050B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00